Home
>
National Drug Code (NDC)
>
SILDENAFIL CITRATE
SILDENAFIL CITRATE - 13668-185-30 - (SILDENAFIL CITRATE)
Drug Information of SILDENAFIL CITRATE
| Product NDC: | 13668-185 |
| Proprietary Name: | SILDENAFIL CITRATE |
| Non Proprietary Name: | SILDENAFIL CITRATE |
| Active Ingredient(s): | 20 mg/1 & nbsp; SILDENAFIL CITRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SILDENAFIL CITRATE
| Product NDC: | 13668-185 |
| Labeler Name: | Torrent Pharmaceuticals Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091479 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121106 |
Package Information of SILDENAFIL CITRATE
| Package NDC: | 13668-185-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (13668-185-30) |
NDC Information of SILDENAFIL CITRATE
| NDC Code | 13668-185-30 |
| Proprietary Name | SILDENAFIL CITRATE |
| Package Description | 30 TABLET in 1 BOTTLE (13668-185-30) |
| Product NDC | 13668-185 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SILDENAFIL CITRATE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121106 |
| Marketing Category Name | ANDA |
| Labeler Name | Torrent Pharmaceuticals Limited |
| Substance Name | SILDENAFIL CITRATE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
